Allergan delivered good results in the third quarter, in spite...

Allergan delivered good results in the third quarter, in spite of the strong U.S. dollar relative to virtually all major currencies. The U.S.-based company reported product sales of $1,391.1 million for the quarter ended Sept. 30, representing a 6.1 percent increase over the same period a year earlier, or 9.4 ...

To continue reading this article subscribe now


Become a member today for full access from just €6,70 a week!

Buying a membership today will give you:

  • Our executive edition of Eyewear Intelligence (Regular PDF format or E-Format) - the must-read for all decision-makers in the industry
  • Weekly E-mail Briefing from the Chief Editor with the lastest analysis and most important industry developments
  • Case studies and best practices on business challenges
  • Guest chronicles, interviews, insights from industry experts and leaders that are shaping the future of the industry
  • Unlimited access to - all insight, analysis and statistics available online
  • Access to over 11,500 articles and analyses in the archive
  • Personal library to save articles and track your key content
  • Powerful search and intuitive navigation
  • Breaking news

Already an Eyewear Intelligence subscriber? Sign in here.